Subjective associations of poor sleep are known to be linked with worse health-related quality of life in Parkinson disease, but correlating objective measures are harder to find. Researchers sought ...
Gemcitabine (G) and irinotecan (CPT-11) as first-line therapy for carcinoma (ca) of unknown primary (CUP): An NCCTG phase II trial This is an ASCO Meeting Abstract from the 2008 ASCO Annual Meeting.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback